| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.06 |